SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
DECEMBER 12, 2001
-----------------
Date of Report
(Date of earliest event reported)
GENUS, INC.
-----------
(Exact name of registrant as specified in its charter)
CALIFORNIA
----------
(State or other jurisdiction of incorporation or organization)
000-17139 94-2790804
--------- ----------
Commission File Number (I.R.S. Employer Identification Number)
1139 KARLSTAD DRIVE
SUNNYVALE, CA 94089
-------------------
(Address of principal executive offices)
(408) 747-7120
--------------
(Registrant's telephone number, including area code)
ITEM 5. OTHER EVENTS
The information that is set forth in the Registrant's Press Release dated
December 12, 2001, is incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
99.1 Press release of Genus, Inc. dated December 12, 2001.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunder duly authorized.
GENUS, INC.
Date: December 12, 2001 /s/Shum Mukherjee
------------------
Shum Mukherjee
Vice President of
Finance and
Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Description
- ------------ -----------
99.1 Press release of Genus, Inc. dated December 12, 2001
COMPANY CONTACT: EDITORIAL CONTACT:
Shum Mukherjee Dave Richardson
Genus, Inc. Positio, Inc.
Tel: (408) 747-7140 Ext. 1311 Tel: (650) 815-1006 Ext.108
smukherjee@genus.com dave@positiopr.com
GENUS PLANS PRIVATE PLACEMENT OF COMMON STOCK
SUNNYVALE, CALIF.-DECEMBER 12, 2001-Genus, Inc. (Nasdaq: GGNS) announced its
intention to obtain financing through a private placement of its common stock
and warrants. The Company expects to price the stock at an average of the
company's common stock value weighted over the five days prior to the execution
of the financing. The company anticipates completing the transaction during the
first quarter, 2002.
Genus plans to use the private placement proceeds to fund the next phases of
commercialization of its atomic layer deposition technology. Primarily this will
include inventory, sales and support to address new customers, working capital,
and will also include general corporate purposes.
The securities offered in the private placement will not be registered under the
Securities Act of 1933 and may not be offered or sold in the United States
without either being registered or being subject to an applicable exemption from
registration requirements.
# # #